Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulthiame Dose-Ranging Study in Obstructive Sleep Apnea
2021-002926-26Phase 2Completed
- Sponsor
- Desitin Arzneimittel
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sultiame in obstructive sleep apnea hypopnea syndrome (OSAHS) (4 arms), sponsored by Desitin Arzneimittel. Primary endpoint: Relative change in AHI from baseline to Week 15. Started Aug 2021; status: completed.
02
Drugs
sultiame
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2021-002926-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002926-26.